Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck KGaA

www.emdgroup.com/en

Latest From Merck KGaA

Embracing China 2.0: AZ, Merck KGaA Set Up Funds, J&J Steps Up Digital Push

AstraZeneca has pledged $1bn to a healthcare fund to support local innovation in China, joining big pharma peers J&J and Merck KGaA in fresh moves to embrace this market, where a new wave of digital technology transformation and fast-shifting trends now favor novel new therapies and the rise of local health start-ups

China Innovation

ObsEva Gives Up On IVF Drug As Phase III Study Fails

Shares plummet as ObsEva announces it is discontinuing its IVF program for nolasiban after disappointing Phase III data from a European confirmatory study.

Clinical Trials Companies

GSK Gears Up For Three Cancer Launches In 2020

After selling off its oncology franchise just five years ago, GSK is poised to re-enter the fray - and is preparing its commercial teams for battle.
Commercial FDA

Mixed Data For Merck KGaA's Disease-Modifying OA Drug

Sprifermin could be the first drug to affect the underlying disease process in osteoarthritis but data show no significant improvement in symptoms.
Inflammation Clinical Trials
See All

Company Information

UsernamePublicRestriction

Register